Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation

Chinese Journal of Cardiology

Volumn 42, Issue 1, 2014, Pages 14-18

  Chen, Jinsong ^a   Chen, Yundai ^a   Tian, Feng ^a   Han, Yunfeng ^a   Jing, Jing ^a   Liu, Jie ^a   Wang, Jing ^a   Zhou, Shanshan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diabetes mellitus; Forecasting; Stents

Indexed keywords

AGED; CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RANDOM ALLOCATION; RETROSPECTIVE STUDIES;

EID: 84893853337     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2014.01.004     Document Type: Article

References (15)

1. Serruys P W, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease[J]. Benestent Study Group. N Engl J Med, 1994, 331:489-495.
2. Zahn R, Hamm C W, Schneider S, et al. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry) [J]. Am J Cardiol, 2005, 95:1302-1308.
3. Mauri L, Silbaugh T S, Wolf R E, et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts [J]. Circulation, 2008, 118:1817-1827.
4. Lemos P A, Serruys P W, van Domburg R T, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry [J]. Circulation, 2004, 109:190-195.
5. Stolker J M, Kennedy K F, Lindsey J B, et al. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry [J]. Circ Cardiovasc Interv, 2010, 3:327-334.
6. Tsigkas G G, Karantalis V, Hahalis G, et al. Stent restenosis, pathophysiology and treatment options: a 2010 update [J]. Hellenic J Cardiol, 2011, 52:149-157.
7. Matsushita K, Mahmoodi B K, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate [J]. JAMA, 2012, 307:1941-1951.
8. Wang J W, Chen Y D, Wang C H, et al. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction [J]. Cardiology, 2013, 124:153-160.
9. Sales R K, Vargas F S, Capelozzi V L, et al. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer [J]. Respirology, 2009, 14:1128-1133.
10. Akcakoyun M, Kargin R, Tanalp A C, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study [J]. Coron Artery Dis, 2008, 19:337-343.
11. Amano T, Matsubara T, Izawa H, et al. Impact of plasma aldosterone levels for prediction of in-stent restenosis [J]. Am J Cardiol, 2006, 97:785-788.
12. Lee J Y, Park D W, Kim Y H, et al. Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease[J]. J Am Coll Cardiol, 2011, 57:1349-1358.
13. Mosseri M, Nahir M, Rozenman Y, et al. Diffuse narrowing of coronary arteries in diabetic patients: the earliest phase of coronary artery disease[J]. Cardiology, 1998, 89:103-110.
14. Yonetsu T, Kato K, Kim S J, et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry [J]. Circ Cardiovasc Imaging, 2012, 5:660-666.
15. Lindsay J, Sharma A K, Canos D, et al. Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C[J]. Cardiovasc Revasc Med, 2007, 8:15-20.